Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
OMNIPAQUE 300 GE HEALTHCARE CANADA INC Resolved 647MG Updated Report 2024-02-24 217417
VISIPAQUE 320 GE HEALTHCARE CANADA INC Resolved 652MG Updated Report 2024-02-24 217420
DETROL BGP PHARMA ULC Actual shortage 1MG Updated Report 2024-02-24 219750
APO-ABIRATERONE FILM COATED TABLETS APOTEX INC Actual shortage 250MG New Report 2024-02-23 220474
APO-ABIRATERONE FILM COATED TABLETS APOTEX INC Actual shortage 250MG New Report 2024-02-23 220471
APO-TRYPTOPHAN APOTEX INC Actual shortage 1G New Report 2024-02-23 220468
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS APOTEX INC Actual shortage 100MG Updated Report 2024-02-23 220465
APO-SIMVASTATIN APOTEX INC Actual shortage 40MG New Report 2024-02-23 220462
APO-DOXYLAMINE/B6 APOTEX INC Actual shortage 10MG 10MG Updated Report 2024-02-23 220459
APO-MONTELUKAST APOTEX INC Actual shortage 10MG Updated Report 2024-02-23 220456
APO-FLUOXETINE APOTEX INC Actual shortage 20MG New Report 2024-02-23 220453
APO-FLUOXETINE APOTEX INC Actual shortage 10MG New Report 2024-02-23 220450
APO-CINACALCET APOTEX INC Actual shortage 30MG New Report 2024-02-23 220447
APO-CEFEPIME APOTEX INC Actual shortage 2G New Report 2024-02-23 220444
APO-DONEPEZIL APOTEX INC Actual shortage 10MG New Report 2024-02-23 220441
APO-QUETIAPINE FUMARATE APOTEX INC Actual shortage 300MG Updated Report 2024-02-23 216708
APO-QUETIAPINE FUMARATE APOTEX INC Actual shortage 25MG Updated Report 2024-02-23 216699
APO-AMLODIPINE-ATORVASTATIN APOTEX INC Actual shortage 80MG 10MG Updated Report 2024-02-23 219843
APO-PRUCALOPRIDE APOTEX INC Actual shortage 1MG Updated Report 2024-02-23 219834
APO-DICLO SR APOTEX INC Actual shortage 100MG Updated Report 2024-02-23 219177
APO-OXCARBAZEPINE APOTEX INC Actual shortage 150MG Updated Report 2024-02-23 219159
APO-MELOXICAM APOTEX INC Actual shortage 1.5G Updated Report 2024-02-23 218379
APO-AMOXI CLAV APOTEX INC Actual shortage 125MG 875MG Updated Report 2024-02-23 217490
APO-GLICLAZIDE APOTEX INC Actual shortage 80MG Updated Report 2024-02-23 217487
APO-SIMVASTATIN APOTEX INC Actual shortage 40MG Updated Report 2024-02-23 203834
APO-AMPHETAMINE XR APOTEX INC Resolved 5MG Updated Report 2024-02-23 216681
APO-AMPHETAMINE XR APOTEX INC Actual shortage 25MG Updated Report 2024-02-23 215964
APO-ZOPICLONE APOTEX INC Resolved 7.5MG Updated Report 2024-02-23 214229
APO-ZOPICLONE APOTEX INC Resolved 5MG Updated Report 2024-02-23 213565
APO-ZOLPIDEM ODT APOTEX INC Resolved 10MG Updated Report 2024-02-23 214235
APO-ZOLPIDEM ODT APOTEX INC Resolved 5MG Updated Report 2024-02-23 212934
APO-TRAZODONE TABLETS 100MG APOTEX INC Actual shortage 100MG Updated Report 2024-02-23 219122
APO-TRAZODONE D TABLETS 150MG APOTEX INC Actual shortage 150MG Updated Report 2024-02-23 215224
APO-METHYLPHENIDATE ER APOTEX INC Resolved 54MG Updated Report 2024-02-23 217300
APO-METHYLPHENIDATE ER APOTEX INC Resolved 54MG Updated Report 2024-02-23 218376
APO-METHYLPHENIDATE ER APOTEX INC Actual shortage 18MG Updated Report 2024-02-23 209298
APO-DICLO APOTEX INC Resolved 50MG Updated Report 2024-02-23 214238
APO-DABIGATRAN APOTEX INC Resolved 110MG Updated Report 2024-02-23 219152
APO-DABIGATRAN APOTEX INC Resolved 150MG Updated Report 2024-02-23 219149
APO-ACETAMINOPHEN CAPLETS APOTEX INC Resolved 325MG Updated Report 2024-02-23 216656
APO-ALFUZOSIN APOTEX INC Actual shortage 10MG Updated Report 2024-02-23 215973
FLAGYL SANOFI-AVENTIS CANADA INC Actual shortage 10% Updated Report 2024-02-23 215793
RESONIUM CALCIUM SANOFI-AVENTIS CANADA INC Resolved 999MG Updated Report 2024-02-23 208624
NUCYNTA EXTENDED-RELEASE ENDO VENTURES LTD. Actual shortage 50MG Updated Report 2024-02-23 214713
NUCYNTA EXTENDED-RELEASE ENDO VENTURES LTD. Actual shortage 200MG Updated Report 2024-02-23 205952
NUCYNTA EXTENDED-RELEASE ENDO VENTURES LTD. Actual shortage 150MG Updated Report 2024-02-23 208783
NUCYNTA EXTENDED-RELEASE ENDO VENTURES LTD. Actual shortage 100MG Updated Report 2024-02-23 194857
DEXEDRINE SPANSULE SRC 15MG PALADIN LABS INC. Actual shortage 15MG New Report 2024-02-23 220374
LUTREPULSE PWS 0.8MG/VIAL FERRING INC Anticipated shortage 0.8MG Updated Report 2024-02-23 220371
CEPHALEXIN SANIS HEALTH INC Actual shortage 250MG Updated Report 2024-02-23 198742

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PROCTOSEDYL APTALIS PHARMA CANADA ULC To be discontinued 1% 1% 0.5% 0.5% New Report 2024-02-23 220351
!!T3 LODALIS BAUSCH HEALTH, CANADA INC. Discontinued 3.75G New Report 2024-02-20 212799
!!T3 FLOMAX CR BOEHRINGER INGELHEIM (CANADA) LTD LTEE Discontinued 0.4MG Updated Report 2024-02-17 213714
DULOXETINE SANIS HEALTH INC To be discontinued 60MG Updated Report 2024-02-15 219591
DULOXETINE SANIS HEALTH INC To be discontinued 30MG New Report 2024-02-15 219618